Vertex Pharmaceuticals sees significant decrease in position by Bleakley Financial Group LLC during Q3.
☀️Trending News Vertex Pharmaceuticals ($NASDAQ:VRTX) Incorporated is a biotechnology company that focuses on developing and commercializing therapies for the treatment [...]
Vertex Pharmaceuticals Intrinsic Value Calculator – ProShare Advisors LLC reduces Vertex Pharmaceuticals holdings by 10.2% in second quarter
🌥️Trending News Vertex Pharmaceuticals ($NASDAQ:VRTX) Incorporated is a global biotechnology company that focuses on developing and commercializing innovative medicines for [...]
Vertex Pharmaceuticals Director Sangeeta N. Bhatia Sells 646 Shares of Company Stock in Recent Transaction
☀️Trending News Vertex Pharmaceuticals ($NASDAQ:VRTX) Incorporated is a biotechnology company that focuses on developing and commercializing therapies for serious diseases. [...]
Vertex Pharmaceuticals Stock Fair Value – Vertex Pharmaceuticals Soars as Diabetes Pain Therapy Succeeds in Mid-Stage Trial
🌥️Trending News Vertex Pharmaceuticals ($NASDAQ:VRTX) has recently seen a surge in stock value after a mid-stage trial for their diabetic [...]
Vertex Pharmaceuticals Intrinsic Value Calculator – VERTEX PHARMACEUTICALS Reports Third Quarter Earnings Results for FY2023
🌥️Earnings Overview On November 6, 2023, Vertex Pharmaceuticals ($NASDAQ:VRTX) reported Q3 earnings for the period ending September 30, 2023, with [...]
Health Canada Grants Expanded Approval of Vertex Pharmaceuticals’ CF Drug for Infants
☀️Trending News Vertex Pharmaceuticals ($NASDAQ:VRTX) has recently been granted expanded approval by Health Canada for its cystic fibrosis (CF) drug, [...]
Vertex Pharmaceuticals Stock Fair Value – VERTEX PHARMACEUTICALS Reports 6.4% Increase in Total Revenue for FY2023 Q3
☀️Earnings Overview Vertex Pharmaceuticals ($NASDAQ:VRTX) reported their financial results for the third quarter of fiscal year 2023 on November 6, [...]
VERTEX PHARMACEUTICALS Reports 13.5% YOY Increase in Total Revenue and 13.0% YOY Increase in Net Income for Q2 FY2023
☀️Earnings Overview On August 1 2023, Vertex Pharmaceuticals ($NASDAQ:VRTX) announced total revenue of USD 2493.2 million and net income of [...]
Vertex Pharmaceuticals Shares Drop 2.97% to $347.74 on Difficult Trading Day
🌧️Trending News Vertex Pharmaceuticals ($NASDAQ:VRTX) Inc. (VRTX) experienced a difficult trading day on Thursday, as their shares dropped by 2.97% [...]
VERTEX PHARMACEUTICALS Announces Q2 Fiscal Year 2023 Earnings Results on August 1 2023
🌥️Earnings Overview Vertex Pharmaceuticals ($NASDAQ:VRTX) released their earnings report for the second quarter of Fiscal Year 2023 (ending June 30 [...]
